HI
TEVA icon

HBK Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

HBK Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,277
Closed -$177K – 1020
2019
Q1 		$177K Sell
11,277
-55,093
-83% -$972K ﹤0.01% 982
2018
Q4 		$1.02M Sell
66,370
-15,530
-19% -$318K 0.01% 682
2018
Q3 		$1.76M Buy
+81,900
New +$1.9M 0.01% 563
2016
Q4 		– Sell
-67,400
Closed -$3.1M – 879
2016
Q3 		$3.1M Sell
67,400
-350,578
-84% -$18.3M 0.03% 284
2016
Q2 		$21M Buy
417,978
+231,378
+124% +$12.3M 0.15% 84
2016
Q1 		$9.98M Buy
186,600
+78,699
+73% +$4.62M 0.1% 143
2015
Q4 		$7.08M Sell
107,901
-232,799
-68% -$14.4M 0.07% 165
2015
Q3 		$19.2M Sell
340,700
-110,300
-24% -$7.15M 0.19% 74
2015
Q2 		$26.7M Buy
451,000
+32,000
+8% +$1.97M 0.27% 61
2015
Q1 		$26.1M Buy
419,000
+49,634
+13% +$2.89M 0.25% 47
2014
Q4 		$21.2M Sell
369,366
-134,375
-27% -$7.49M 0.26% 59
2014
Q3 		$27.1M Buy
503,741
+4,348
+0.9% +$230K 0.42% 41
2014
Q2 		$26.2M Buy
499,393
+377,793
+311% +$19.3M 0.53% 36
2014
Q1 		$6.42M Buy
121,600
+400
+0.3% +$18.5K 0.12% 134
2013
Q4 		$4.86M Buy
121,200
+12,783
+12% +$503K 0.09% 147
2013
Q3 		$4.1M Sell
108,417
-14,083
-11% -$549K 0.06% 173
2013
Q2 		$4.8M Buy
+122,500
New +$4.77M 0.07% 141

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HBK Investments's TEVA Position: Q2 2019 in Review

HBK Investments sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 11,277 shares — an estimated $177K sold.

HBK Investments first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $27.1M in Q3 2014. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • HBK Investments reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 11,277 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $177K.
  • HBK Investments first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 17 quarters.
  • HBK Investments's Teva Pharmaceutical Industries Limited position peaked at $27.1M in Q3 2014.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.